Fresh analysis suggests that people who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop conventional diet and exercise programs.
Published data in a leading health publication demonstrates that while overweight individuals frequently drop about a fifth of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"Users using such medications should be cognizant of the potential of quick rebound weight gain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
This pace of regain implies a reversion to pre-treatment mass within about a year and a half.
Comparing Therapies
The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Scientists emphasize that people who shed pounds through lifestyle changes alone generally see a more gradual creep back—approximately 100 grams monthly—after stopping.
Explaining the Rapid Rebound
Experts suggest the way of the jabs explains the heightened rebound.
These medications mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making overeating much more probable."
A Chronic Issue?
Medical guidelines recommend the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, considering the significant potential of relapse, the therapy might need to be long-term.
This perspective is reinforced by pharmaceutical companies, who say that the results "emphasize the persistent character of excess weight," comparing it to managing diseases like hypertension.
Patient Experiences
Individuals who have discontinued the jabs describe a sudden resurgence of cravings.
"I experienced a trigger activating and I was suddenly extremely hungry," said a patient.
This challenge is compounded if patients have not adopted lasting dietary or behavioural modifications during therapy.
Significant Interest
Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is more common among women than males.
- The middle-aged demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while the jabs are powerful tools for shedding pounds, they are not a standalone fix and long-term success relies on ongoing lifestyle management.
